Over the past few decades, American parents have been pressured into making a costly wager: If they sacrifice their hobbies, interests, and friendships to devote as much time and as many resources as possible to parenting, they might be able to launch their children into a stable adulthood. While this gamble sometimes pays off, parents who give themselves over to this intensive form of child-rearing may find themselves at a loss when their children are grown and don’t need them as much.

Prior generations didn’t need to be as preoccupied with their children’s well-being or future. Growing up in Dayton, Ohio, in the 1960s, my brothers and I were as luxuriously removed from our parents’ minds as they were from ours. It was the gilded age of childhood freedom. My brothers and I consumed hours of television and ate staggering amounts of sugar—for breakfast. We vanished each summer morning, biked back for lunch, and then disappeared again ’til dusk. My parents also had a life. My mother played mah-jongg weekly with “the girls” and went out every weekend with my father without calling it “date night.” My dad played squash on weekends at the downtown YMCA and didn’t seem to worry about whether my brothers and I felt neglected.

For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.

The world is now engaged in a vaccination program unlike anything we have seen in our lifetimes, and with it, unprecedented scrutiny of ultra-rare but dangerous side effects. An estimated 852 million COVID-19 vaccine doses have been administered across 154 countries, according to data collected by Bloomberg. Last week, the European Medicines Agency, which regulates medicines in the European Union, concluded that the unusual clotting events were indeed a side effect of the AstraZeneca vaccine; by that point, more than 220 cases of dangerous blood abnormalities had been identified. Only half a dozen cases have been documented so far among Americans vaccinated with the Johnson & Johnson vaccine, and a causal link has not yet been established. But the latest news suggests that the scope of this problem might be changing.

Last week, the CDC acknowledged what many of us have been saying for almost nine months about cleaning surfaces to prevent transmission by touch of the coronavirus: It’s pure hygiene theater.

“Based on available epidemiological data and studies of environmental transmission factors,” the CDC concluded, “surface transmission is not the main route by which SARS-CoV-2 spreads, and the risk is considered to be low.” In other words: You can put away the bleach, cancel your recurring Amazon subscription for disinfectant wipes, and stop punishing every square inch of classroom floor, restaurant table, and train seat with high-tech antimicrobial blasts. COVID-19 is airborne: It spreads through tiny aerosolized droplets that linger in the air in unventilated spaces. Touching stuff just doesn’t carry much risk, and more people should say so, very loudly.

A year ago, when the United States decided to go big on vaccines, it bet on nearly every horse, investing in a spectrum of technologies. The safest bets, in a way, repurposed the technology behind existing vaccines, such as protein-based ones for tetanus or hepatitis B. The medium bets were on vaccines made by Johnson & Johnson and AstraZeneca, which use adenovirus vectors, a technology that had been tested before but not deployed on a large scale. The long shots were based on the use of mRNA, the newest and most unproven technology.

The protein-based vaccines have moved too slowly to matter so far. J&J’s and AstraZeneca’s vaccines are effective at preventing COVID-19—but a small number of recipients have developed a rare type of blood clot that appears to be linked to the adenovirus technology and may ultimately limit those shots’ use. Meanwhile, with more than 180 million doses administered in the U.S, the mRNA vaccines have proved astonishingly effective and extremely safe. The unusual blood clots have not appeared with Pfizer’s or Moderna’s mRNA technology. A year later, the risky bet definitely looks like a good one.

Illustrations by Leonardo Santamaria

This article was published online on April 15, 2021.

The Motel El Encanto in Hermosillo, Mexico, served a lavish breakfast that John and Andra Patterson liked to eat on the tiled deck near their suite. The couple would discuss the day ahead over fresh pineapple and pan dulces while their 4-year-old daughter, Julia, watched the gray cat that skulked about the motel’s Spanish arches.

On the morning of March 22, 1974, the Pattersons’ breakfast chatter centered on their search for a permanent home. They were nearing their two-month anniversary of living in Hermosillo, where John was a junior diplomat at the American consulate, and the motel was feeling cramped.

After breakfast, Andra dropped John off at work. Because this was his first posting as a member of the United States Foreign Service, the 31-year-old Patterson had been given an unglamorous job: He was a vice consul responsible for promoting trade between the U.S. and Mexico, which on this particular Friday meant driving out to meet with a group of ranchers who hoped to improve their yield of beef.

Aviation deaths once looked like an intractable problem. Then the federal government began probing every plane crash with an eye toward preventing future loss of life. Our skies got much safer as a result. A similar approach could reduce police killings. A federal agency should investigate every single killing and significant injury caused by American police officers, who have long killed people at higher rates than cops in many other wealthy democracies.

Police killings and protests against them have loomed large in United States politics for at least the past seven years. Right now the nation is focused most closely on the trial of Derek Chauvin, who infamously knelt on George Floyd’s neck, even as new protests erupt in Minneapolis over the killing of Daunte Wright, who was shot to death by a police officer who says she intended to discharge her taser. On Thursday, the city of Chicago released footage of the fatal police shooting of 13-year-old Adam Toledo.

A trio of boys tramps along the length of a wooden fence, back and forth, shouting like carnival barkers. “The Land! It opens in half an hour.” Down a path and across a grassy square, 5-year-old Dylan can hear them through the window of his nana’s front room. He tries to figure out what half an hour is and whether he can wait that long. When the heavy gate finally swings open, Dylan, the boys, and about a dozen other children race directly to their favorite spots, although it’s hard to see how they navigate so expertly amid the chaos. “Is this a junkyard?” asks my 5-year-old son, Gideon, who has come with me to visit. “Not exactly,” I tell him, although it’s inspired by one. The Land is a playground that takes up nearly an acre at the far end of a quiet housing development in North Wales. It’s only two years old but has no marks of newness and could just as well have been here for decades. The ground is muddy in spots and, at one end, slopes down steeply to a creek where a big, faded plastic boat that most people would have thrown away is wedged into the bank. The center of the playground is dominated by a high pile of tires that is growing ever smaller as a redheaded girl and her friend roll them down the hill and into the creek. “Why are you rolling tires into the water?” my son asks. “Because we are,” the girl replies.

Debbie Gustafson of Dresher, Pennsylvania, was on the trip of a lifetime, touring the Galápagos with her family last March, when she began to feel the effects of COVID-19. Though her physical symptoms—diarrhea, dry cough, chills—were considered mild by doctors, her fatigue was crushing, and her mind was trapped in a fog. Once an avid reader, she couldn’t get through a page. “My eyes darted everywhere. I had no focus,” she told me. Before COVID-19, she’d held two part-time jobs, but she soon had to give up both of them.

The cognitive problems emerging from mild to moderate cases of COVID-19 are so new that researchers have struggled to define them. A just-published study led by Igor Koralnik, the director of the Neuro COVID-19 Clinic at Chicago’s Northwestern Memorial Hospital, analyzed the first 100 “long COVID” sufferers who came to the clinic, either in person or via virtual visits. None had ever been hospitalized for COVID-19, yet 85 percent had four or more neurological complaints, including “brain fog”—persistent trouble with focusing, retaining short-term memories, and managing complex tasks.  

In 2015, in the Dallas suburb of Irving, the fates of two very different Texans collided.

One was 14-year-old Ahmed Mohamed, a precocious kid in a NASA T-shirt who had built a clock out of spare parts and brought it to school in a pencil case. His English teacher decided it might be a bomb, and the school called the police, who arrested Mohamed for bringing in a “hoax bomb.” Because Mohamed’s family was part of Irving’s large Muslim minority, many liberals saw this as a baseless case of Islamophobia.

The other Texan was Irving Mayor Beth Van Duyne, a blond 44-year-old with Disney-princess bone structure. She defended Mohamed’s arrest on Facebook, then went on The Glenn Beck Program to repeat the “hoax bomb” lie and complain that the child hadn’t given police enough information. “We’ve heard more from the media than the child ever released to the police when we were asking him questions,” she said calmly.

Updated at 5:57 p.m. ET on January 14, 2020.

On a recent Saturday afternoon, I stood with my 13-year-old son in a long line stretching over the West Side Highway, cars careening below us. He was waiting to take an entrance exam for a specialized high school, a sacred moment, and yet I kept glancing at my phone to check the time. I had to meet my mother to tour an apartment because my childhood home in the East Village had burned down the week prior—a month after my father was diagnosed with late-stage lung cancer. My parents, who are in their 70s, were too overwhelmed to handle the logistics of finding a sublet on their own. On that day, and just about every day these past few months, I had to choose between caring for one family member or another. With so many crises under way, caring for myself hasn’t really been on the table.